A Real World Data of Ocrelizumab in Multiple Sclerosis

被引：0
作者：
Beckmann, Y.
Uzunkopru, C.
机构：
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1240
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
[31]   Findings from a large monocentric real-world experience of Ocrelizumab use in Multiple Sclerosis [J].
Mellino, Paolo ;
Pilotto, Silvy ;
Frau, Jessica ;
Carmagnini, Daniele ;
Coghe, Giancarlo ;
Cocco, Eleonora ;
Lorefice, Lorena .
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 :613-614
[32]   Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients [J].
Prockl, Victoria ;
Nickel, Florian T. ;
Utz, Kathrin S. ;
Froehlich, Kilian ;
Engelhorn, Tobias ;
Hilz, Max-Josef ;
Lee, De-Hyung ;
Linker, Ralf A. ;
Huhn, Konstantin .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 415
[33]   Ocrelizumab for multiple sclerosis [J].
Lin, Mengbing ;
Zhang, Jian ;
Zhang, Yueling ;
Luo, Jiefeng ;
Shi, Shengliang .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05)
[34]   Ocrelizumab two-year real-world safety and effectiveness over in the treatment of multiple sclerosis [J].
Vollmer, Brandi ;
Ijadi, Nassim ;
Declusin, Anthony ;
Nair, Kavita ;
Sillau, Stefan ;
Corboy, John ;
Vollmer, Timothy ;
Alvarez, Enrique .
NEUROLOGY, 2021, 96 (15)
[35]   Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience [J].
Cellerino, M. ;
Boffa, G. ;
Lapucci, C. ;
Sbragia, E. ;
Bruschi, N. ;
Mancuso, E. ;
Tazza, F. ;
Poire, I. ;
Laroni, A. ;
Capello, E. ;
Uccelli, A. ;
Novi, G. ;
Inglese, M. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :295-295
[36]   Real-world experience with Ocrelizumab in Multiple Sclerosis patients: Two years follow up in Qatar [J].
Yousuf, Wajiha ;
Ganesan, Gowrii Saswathy ;
Humos, Basel ;
Baig, Tehniyat ;
Canibano, Beatriz ;
Deleu, Dirk .
NEUROLOGY, 2021, 96 (15)
[37]   A real-world analysis of ocrelizumab treatment patterns among multiple sclerosis patients in saskatchewan, canada [J].
Saini, A. ;
Poliakov, I. ;
Knox, K. ;
Kahovec, C. ;
Jata, A. ;
Macgowan, S. ;
Levin, M. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :323-323
[38]   Switching from ocrelizumab to cladribine: real world data [J].
O'Neill, D. ;
Sharma, M. ;
Gonzales, B. ;
Vandenheuval, M. ;
Tse, B. ;
Hodgkinson, S. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) :311-311
[39]   Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) [J].
Chisari, Clara G. ;
Bianco, Assunta ;
Morra, Vincenzo Brescia ;
Calabrese, Massimiliano ;
Capone, Fioravante ;
Cavalla, Paola ;
Chiavazza, Carlotta ;
Comi, Cristoforo ;
Danni, Maura ;
Filippi, Massimo ;
Iaffaldano, Pietro ;
Lanzillo, Roberta ;
Lo Fermo, Salvatore ;
Lucisano, Alessandra ;
Lugaresi, Alessandra ;
Lus, Giacomo ;
Marfia, Gerolama Alessandra ;
Marinelli, Fabiana ;
Mirabella, Massimiliano ;
Moiola, Lucia ;
Perin, Chiara ;
Realmuto, Sabrina ;
Toscano, Simona ;
Trojano, Maria ;
Vecchio, Domizia ;
Patti, Francesco .
NEUROTHERAPEUTICS, 2023, 20 (06) :1696-1706
[40]   Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience [J].
Cellerino, Maria ;
Boffa, Giacomo ;
Lapucci, Caterina ;
Sbragia, Elvira ;
Bruschi, Nicolo ;
Mancuso, Elisabetta ;
Tazza, Francesco ;
Poire, Ilaria ;
Laroni, Alice ;
Capello, Elisabetta ;
Uccelli, Antonio ;
Novi, Giovanni ;
Inglese, Matilde .
NEUROLOGY, 2021, 96 (15)
12345